Jefferies Remains a Buy on Amgen (AMGN) | Markets Insider
Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s s...
Value Investor
2025-01-17
Comments
Share your comments